32780-32-8 Pt 141 Peptide , Pt 141 Bremelanotide 2mg / Vial 98.0% Min Purity peptide for gain muscles

Peptides PT-141 Cas No. 32780-32-8 white powder Peptide series hot sell 2mg/vial

1. Quick Detail:

Cas No.: 32780-32-8
Mf:C7h15no4
Purity (HPLC): 98.0%min.
Appearance: White powder
Single Impurity (HPLC): 1.0%max
Amino Acid Composition: ±10% of theoretical
Peptide Content (N%):  ≥80.0%
Water Content(Karl Fischer):  ≤6.0%
Acetate Content (HPIC):  ≤15.0%
MS(ESI):  Consistent
Mass Balance: 95.0~105.0%

2. Description:

PT-141 functions by activating the melanocortin 1 receptor and MC4R namely. Bremelanotide originally was tested for nasal spray delivery but was discontinued after concerns about side effects. Bremelanotide PT141, as Melanotan II, may cause spontaneous arousal enhancing effect. Unlike other supplements, pt 141 results do not act on the vascular body, but directly increases desires through the nervous system.
Bremelanotide PT-141 Peptide Synthesis Information
Our PT141 delivers 99% purity ratings, HPLC quality tested PT-141 10MG. Furthermore, bremelanotide triggers the melanocortin system to cascade variably to melanocortin receptors, more than PDE5 meds. Small-structure biologic melanocortin peptides molecule remains potent during shipping as well as in storage. Melanotan 2 and PT141 melanocortins do not require cold shipping to remain effective. Products stay potent and should not expire until years later when stored properly in the fridge or freezer.

3. PT-141 (Bremelanotide) at a Glance
According to scientific study that has been performed on animal test subjects, PT-141 (Bremelanotide) works by activating the melanocortin recptors MC3-R and MC4-R in the central nervous system. This interaction allows the peptide to regulate brain transmissions that are sent to the parts of the central nervous system tied to blood flow restriction and inflammation. In essence, the peptide’s functionality could cause a curtailing of inflammation that may otherwise be triggered by various irritants or pathogens. It could also cause a reduction of the damage that may otherwise occur within blood vessels and their associative tissues – damage that could be directly linked to the wake of an incident tied to ischemia.

Because of PT (Bremelanotide)’s ability to regulate blood flow restriction and inflammation, scientific study based on animal test subjects has determined that the peptide may be instrumental in managing the onset of hemorrhagic shock and reperfusion injury. It is thought that it could aid in the former condition because it can boost sympathetic outflow to the heart and other organs that may otherwise slow down or stop altogether. It is thought that it could aid in the latter because it could possibly lessen the kinds of blockages that are typically associated to blood flow restriction to tissues in the aftermath of the ischemic cascade.